[ad_1]

Jun 12, 2021, 09:05PM ISTSource: Times Now

Bharat Biotech shared complete data of phase-I and phase II and partial data for phase -III Covaxin has been examined by the regulators. The company said that it is committed to data transparency and will soon be making the results from the final analysis of the efficacy trials public.



[ad_2]